Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics
Lantheus Holdings, Inc. (LNTH)
Today's Latest Price: $13.17 USD
Updated Nov 27 1:00pm
Add LNTH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
LNTH Stock Summary
- LNTH's went public 5.43 years ago, making it older than only 19.26% of listed US stocks we're tracking.
- LNTH's current price/earnings ratio is 2,234.78, which is higher than 99.54% of US stocks with positive earnings.
- In terms of volatility of its share price, LNTH is more volatile than just 14.33% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Lantheus Holdings Inc, a group of peers worth examining would be KRNT, JVA, CYBR, NOK, and CAAS.
- Visit LNTH's SEC page to see the company's official filings. To visit the company's web site, go to www.lantheus.com.
LNTH Stock Price Chart Interactive Chart >
LNTH Price/Volume Stats
| Current price | $13.17 | 52-week high | $21.42 |
| Prev. close | $13.00 | 52-week low | $8.67 |
| Day low | $12.97 | Volume | 97,926 |
| Day high | $13.21 | Avg. volume | 531,167 |
| 50-day MA | $12.46 | Dividend yield | N/A |
| 200-day MA | $13.33 | Market Cap | 880.69M |
Lantheus Holdings, Inc. (LNTH) Company Bio
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.
LNTH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $13.17 | $11.98 | -4% |
Below please find a table outlining a discounted cash flow forecast for LNTH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Lantheus Holdings Inc ranked in the 46th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for LNTH, they are:
- Lantheus Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 163 -- greater than 98.64% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 11. This value is greater than 82.92% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -6% |
| 1% | -5% |
| 2% | -4% |
| 3% | -3% |
| 4% | -2% |
| 5% | -1% |
USPH, MMSI, PAHC, IART, and AMGN can be thought of as valuation peers to LNTH, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...